Intrathecal drug delivery (IDD) is an innovative approach ... and advancements in IDD systems, highlighting their potential benefits for patients who do not respond well to conventional pain ...

SynchroMedII Intrathecal Drug Delivery System That's the news on January 10, 2018 as the company announced the FDA approval of the new clinician programmer for use with the SynchroMedII Intrathecal ...

The blood–brain barrier is the biggest challenge to the development of drugs that target the CNS. Most capillary beds leak plasma contents between and across endothelial cells by way of window-like ...

That's important, as Zolgensma is the world's most expensive drug, costing more than $2.1 million for a one-shot dose. Intrathecal delivery could kickstart sales of Zolgensma, which have taken a ...

Recent systematic reviews were unable to find randomised controlled trials evaluating the effectiveness of long-term intrathecal drug delivery systems for the management of chronic non-cancer pain. We ...

chronic pain hypogonadism drug delivery systems, implantable bone density This is an open ... Hypogonadism is common in intrathecal opioid therapy patients, but there is a dearth of literature ...

We will report on the experience with intrathecal drug delivery across these two studies and present information on suggested best practices in HD. Procedure-related videos will be shared, including ...

His research interests include all aspects of device-related pain management (spinal cord stimulators and intrathecal drug delivery systems). He also serves as a Reviewer for several pain journals.